SpringWorks Therapeutics Highlights Nirogacestat Clinical :

- Initial Data to be Presented from GSK-Sponsored Phase 1/2 Study Evaluating Nirogacestat in Combination with Low-Dose BLENREP in Patients with Relapsed or...

Related Keywords

South Korea , United States , France , Chicago , Illinois , Coindre , Auvergne , Han , American , Osullivan Coyne , Belantamab Mafodotin , Samantha Hilson Sandler , Saqib Islam , Geraldine Helen Osullivan Coyne , Diagnosis National Cancer Institute , Desmoid Working Group , American Society Of Clinical Oncology , National Cancer Institute , Emory University , Developmental Therapeutics Clinic Division Of Cancer Treatment , Nasdaq , European Consensus Initiative , Springworks Therapeutics Inc , Dana Farber Cancer Institute , Department Of Hematology , Winship Cancer Institute , Fred Hutchinson Cancer Research Center , Division Of Cancer Treatment , Desmoid Tumor Working Group , European Organization For Research , European Commission , Drug Administration , Bone Sarcoma Group , Sponsored Phase , Evaluating Nirogacestat , Refractory Multiple Myeloma , Term Follow Up Data , Progressing Desmoid Tumors Also , Works Therapeutics , Clinical Oncology , Annual Meeting , Chief Executive Officer , Low Dose Belantamab Mafodotin , Gamma Secretase Inhibitor , Sagar Lonial , Chair Department , Medical Oncology , Progression Free Survival , Long Term Safety , Desmoid Tumors , Geraldine Heleno Sullivan Coyne , Developmental Therapeutics , Early Clinical Trials Development Program , Cancer Treatment , National Cancer , Orphan Drug Designation , Fast Track , Breakthrough Therapy Designations , Private Securities Litigation Reform Act , Springwork Quarterly Report , Investor Relations , Hilson Sandler , Secretase Inhibitor , Adults With Desmoid Tumors , Aggressive Fibromatosis , Cancer Journal , Accessed May , Desmoid Working , European Organization , Soft Tissue , Mayo Clinic , Report Series , Rare Diseases , Desmoid Tumor Working , Nasdaq Swtx , Springworks Therapeutics , Nc ,